Oracle Launches Oracle Agile PLM 9.3.1

Oracle has announced Oracle’s Agile Product Lifecycle Management (PLM) 9.3.1 to help companies streamline drug development processes, reduce waste, leverage global networks and enable Quality by Design (QbD) practices.

Oracle’s Product Value Chain solution includes Oracle’s Agile PLM, Oracle Product Hub, Oracle’s AutoVue Enterprise Visualisation and Oracle Product Data Quality. Relying on these offerings, customers can manage all product information, integrate product lifecycle processes and benefit from secure collaboration, data quality and knowledge management.

Streamlining and Enhancing Product Value Chain Processes

The existing and new Agile Enterprise PLM capabilities for pharmaceutical organisations include:
-
Drug development portfolio management
- Comprehensive drug development records
- Clinical supply management
- Technology transfer
- Integrated packaging and label management
- Global product registration
- New Enhancements in Agile Product Lifecycle Analytics
- Agile Next Generation CAD Connectors
- Agile Design Variant Management

“Agile PLM 9.3.1 is highly complementary to our other significant investments and capabilities within Life Sciences,” said Neil de Crescenzo, Senior Vice President and General Manager, Health Sciences Global Business Unit, Oracle. “With the new Agile PLM capabilities and our recent acquisition of Phase Forward we have a comprehensive solution for clinical trials and clinical supply management.”